Cargando…
Treatment of toxic epidermal necrolysis and concurrent COVID-19-associated hyperinflammatory syndrome with systemic corticosteroids and etanercept
Autores principales: | Choi, Rachel, Garritano, James, Laird, Mary, Johnston, Margaret, Tkachenko, Elizabeth, Damsky, William, Little, Alicia J., McNiff, Jennifer, Girardi, Michael, Nelson, Caroline A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9485430/ https://www.ncbi.nlm.nih.gov/pubmed/36160836 http://dx.doi.org/10.1016/j.jdcr.2022.09.009 |
Ejemplares similares
-
Cephradine-Induced Toxic Epidermal Necrolysis: A Case Report of Treatment With Etanercept
por: Hubail, Rawan, et al.
Publicado: (2022) -
Toxic Epidermal Necrolysis
por: Khalifian, Saami, et al.
Publicado: (2014) -
Toxic epidermal necrolysis
por: Hoetzenecker, Wolfram, et al.
Publicado: (2016) -
Toxic Epidermal Necrolysis Caused by Apalutamide: A Case Report of Treatment Using Etanercept with Conventional Steroid Therapy
por: OSAWA, Kana, et al.
Publicado: (2022) -
Review of Toxic Epidermal Necrolysis
por: Harris, Victoria, et al.
Publicado: (2016)